10x Genomics, Inc. TXG Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s contract liabilities?
- 10x Genomics, Inc. (TXG) reported contract liabilities of $10.14M in Q1 2026.
- How has 10x Genomics, Inc.'s contract liabilities changed year-over-year?
- 10x Genomics, Inc.'s contract liabilities decreased by 19.3% year-over-year, from $12.57M to $10.14M.
- What is the long-term trend for 10x Genomics, Inc.'s contract liabilities?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s contract liabilities has grown at a 11.1% compound annual growth rate (CAGR), from $6.2M to $10.5M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.